Neurogene Inc. (NGNE) News
Follow Neurogene Inc. (NGNE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Neurogene to participate in H.C. Wainwright 28th conference
Neurogene management will participate in the H.C. Wainwright 28th Annual Global Investment Conference, the company said.
EQUITY | Sep 08, 2026, 11:30 AM UTC
L
Neurogene board panel approves Nasdaq Rule 5635 inducement stock option grants
Neurogene said its Compensation Committee approved non-qualified stock option inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 04, 2026, 08:01 PM UTC
L
Neurogene shares are trading lower after the company announced a proposed public offering.
Neurogene shares are trading lower after the company announced a proposed public offering.
EQUITY | Jun 30, 2026, 08:04 PM UTC
L
Neurogene Reveals Proposed Public Offering; No Size Disclosed
Neurogene Inc. (NASDAQ: NGNE ), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that it has commenced a public of
EQUITY | Jun 30, 2026, 08:02 PM UTC